Metabolic fate of [14C]-ceftizoxime, a parenteral cephalosporin antibiotic, in rats and dogs. 1980

K Noda, and A Suzuki, and H Ohta, and T Furukawa, and H Noguchi

The metabolic fate of (6R,7R)-7-[(Z)-2-(2-amino-4-thiazoyl)-2-methoxyiminoacetamido]-8-oxo-5-thia-1-a zabicyclo[4,2,0]oct-2-ene-2-carboxylic acid (ceftizoxime), a new cephalosporin antibiotic for injection, was investigated in rats and dogs after i.v. dosing. Ceftizoxime was rapidly and widely distributed in the whole body of rats except the brain. The concentrations were high in the serum as well as in the kidneys, liver, lungs, trachea and skin. A small amount of radioactivity passed the placenta. Serum levels of ceftizoxime declined with a half-life of 0.22 h in rats and 0.98 h in dogs. Most of the serum radioactivity was present as unchanged ceftizoxime in dogs. Urinary excretion was rapid and this elimination route was predominant in the two species. Small amounts of metabolites of ceftizoxime were found in the rat urine and bile, however, a major portion of the given dose was excreted in unchanged form. In dogs, ceftizoxime was resistant to metabolic degradation in the body.

UI MeSH Term Description Entries
D008297 Male Males
D002511 Cephalosporins A group of broad-spectrum antibiotics first isolated from the Mediterranean fungus ACREMONIUM. They contain the beta-lactam moiety thia-azabicyclo-octenecarboxylic acid also called 7-aminocephalosporanic acid. Antibiotics, Cephalosporin,Cephalosporanic Acid,Cephalosporin,Cephalosporin Antibiotic,Cephalosporanic Acids,Acid, Cephalosporanic,Acids, Cephalosporanic,Antibiotic, Cephalosporin,Cephalosporin Antibiotics
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D005243 Feces Excrement from the INTESTINES, containing unabsorbed solids, waste products, secretions, and BACTERIA of the DIGESTIVE SYSTEM.
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001345 Autoradiography The making of a radiograph of an object or tissue by recording on a photographic plate the radiation emitted by radioactive material within the object. (Dorland, 27th ed) Radioautography
D001646 Bile An emulsifying agent produced in the LIVER and secreted into the DUODENUM. Its composition includes BILE ACIDS AND SALTS; CHOLESTEROL; and ELECTROLYTES. It aids DIGESTION of fats in the duodenum. Biliary Sludge,Sludge, Biliary
D001711 Biotransformation The chemical alteration of an exogenous substance by or in a biological system. The alteration may inactivate the compound or it may result in the production of an active metabolite of an inactive parent compound. The alterations may be divided into METABOLIC DETOXICATION, PHASE I and METABOLIC DETOXICATION, PHASE II.
D013045 Species Specificity The restriction of a characteristic behavior, anatomical structure or physical system, such as immune response; metabolic response, or gene or gene variant to the members of one species. It refers to that property which differentiates one species from another but it is also used for phylogenetic levels higher or lower than the species. Species Specificities,Specificities, Species,Specificity, Species
D014018 Tissue Distribution Accumulation of a drug or chemical substance in various organs (including those not relevant to its pharmacologic or therapeutic action). This distribution depends on the blood flow or perfusion rate of the organ, the ability of the drug to penetrate organ membranes, tissue specificity, protein binding. The distribution is usually expressed as tissue to plasma ratios. Distribution, Tissue,Distributions, Tissue,Tissue Distributions

Related Publications

K Noda, and A Suzuki, and H Ohta, and T Furukawa, and H Noguchi
July 1977, Antimicrobial agents and chemotherapy,
K Noda, and A Suzuki, and H Ohta, and T Furukawa, and H Noguchi
July 1983, Antimicrobial agents and chemotherapy,
K Noda, and A Suzuki, and H Ohta, and T Furukawa, and H Noguchi
July 1978, Antimicrobial agents and chemotherapy,
K Noda, and A Suzuki, and H Ohta, and T Furukawa, and H Noguchi
July 1978, The Journal of antibiotics,
K Noda, and A Suzuki, and H Ohta, and T Furukawa, and H Noguchi
October 1980, Antimicrobial agents and chemotherapy,
K Noda, and A Suzuki, and H Ohta, and T Furukawa, and H Noguchi
January 1980, Arzneimittel-Forschung,
K Noda, and A Suzuki, and H Ohta, and T Furukawa, and H Noguchi
December 1975, Life sciences,
K Noda, and A Suzuki, and H Ohta, and T Furukawa, and H Noguchi
November 1979, Antimicrobial agents and chemotherapy,
K Noda, and A Suzuki, and H Ohta, and T Furukawa, and H Noguchi
January 1980, Toxicology and applied pharmacology,
K Noda, and A Suzuki, and H Ohta, and T Furukawa, and H Noguchi
July 1995, Antimicrobial agents and chemotherapy,
Copied contents to your clipboard!